Todd Akin on Stem Cell Research

Last Updated : Oct 22, 2012

Summary

Embryos for Research

In 2001, Congressman Akin stated that he was a strong supporter of stem cell research, but not research that destroys human embryos. He was a cosponsor of the Responsible Stem Cell Research Act of 2001, which would establish a stem cell donor bank and authorize $30 million in funding for ethical, adult stem cell research for fiscal year 2002.

Adult Stem Cell Research

In 2005, Congressman Akin supported legislation to use adult stem cell research. He stated that adult and cord blood stem cell research does not necessitate destruction of human embryos for the purposes of scientific research, but it has been showing substantial promise in the actual treatment of disease. He added that embryos are persons at an early stage of development, and deserve the protection of law.

Stem Cell Research Enhancement Act of 2005

In opposing the Stem Cell Research Enhancement Act of 2005, Congressman Akin spoke on the House floor in opposition to public funding for the destruction of human embryos. He stated that the reason for this was very simple in that you and I were once embryos.

Stem Cell Therapeutic and Research Act of 2005

In 2005, Congressman Akin supported the Stem Cell Therapeutic and Research Act of 2005. In supporting the legislation, Congressman Akin stated that it would encourage one of the most promising, and ethically sound, avenues of medical research in our time: The stem cells within umbilical cord blood.

Opposition to Federal Funding

In 2007, Congressman Akin renewed his opposition to federal funding for embryonic stem cell research. He stated that he opposed increasing federal funding for research that necessitates the destruction of a human embryo because embryos are persons at an early stage of development, and deserve the protection of law.

 

Denouncing Embryos for Research

In July of 2001, Congressman Akin issued a press statement noting his view that human embryos should not be created for the purposes of research.

 

Ethical Stem Cell Research

In May of 2005, Congressman Akin released a press statement noting his support for ethical stem cell research.

 

Stem Cell Research Enhancement Act of 2005

In May of 2005, Congressman Akin spoke on the House floor in opposition to public funding for the destruction of embryos.

 

Stem Cell Therapeutic and Research Act of 2005

In May of 2005, Congressman Akin spoke on the House floor in support of the Stem Cell Therapeutic and Research Act of 2005.

 

Opposition to Federal Funding

In January of 2007, Congressman Akin released a press statement noting his opposition to the federal funding of embryonic stem cell research.

 

Reaction to Presidential Veto

In March of 2009, Congressman Akin released a press statement noting his opposition to President Obama's overturning of previous policy to fund embryonic stem cell research.

 

Voting Record

Stem Cell Research Enhancement Act of 2007

The bill came back up for another vote in roll call 443 where it passed 247-146 before it was vetoed by President Bush. Todd Akin voted against the Stem Cell Research Enhancement Act of 2007.

Todd Akin voted against the Stem Cell Research Enhancement Act of 2007.

Stem Cell Research Enhancement Act of 2007

In January 2007, the Senate passed S 5 - the Stem Cell Research Enhancement Act with wide support from Democrats and moderate support from Republicans. The Act required the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Specific limitations were put in place to ensure that the embryos would not have been used for other purposes and were not created specifically for research. The bill passed both the house and senate, but was vetoed by President Bush. Todd Akin voted against the Stem Cell Research Enhancement Act of 2007.

Todd Akin voted against the Stem Cell Research Enhancement Act of 2007.

Stem Cell Research Enhancement Act of 2005

In 2006, an initial effort to pass a stem cell research bill through congress was also vetoed by President Bush. The veto override failed to achieve the necessary 2/3 majority.. Todd Akin voted against overturning the veto on the Stem Cell Research Enhancement Act of 2005.

Todd Akin voted against overturning the veto on the Stem Cell Research Enhancement Act of 2005.

The Alternative Pluripotent Stem Cell Therapies Enhancement Act

In 2006, the Senate passed the Alternative Pluripotent Stem Cell Therapies Enhancement Act. Although it was widely supported in the Senate, it did not reach the 2/3 necessary to pass the House without objection in a 273-154 vote. Todd Akin voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

Todd Akin voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

Stem Cell Therapeutic and Research Act of 2005

In 2005, Congress passed the Stem Cell Therapeutic and Research Act of 2005. The bill set up requirements for the Secretary of Health and Human Services to contract with qualified cord blood stem cell banks to assist in the '); echo('collection and maintenance of 150,000 new units of high-quality cord blood to be made available for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill passed almost unanimously in roll call 205. Todd Akin voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

Todd Akin voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

Stem Cell Research Enhancement Act

In May of 2005, the House passed the Stem Cell Research Enhancement Act. This legislation would have allowed research on human embryonic stem cells created after President Bush's 2001 deadline. The measure passed the House and Senate, but was vetoed. It passed the House 238-194. Todd Akin voted against the Stem Cell Research Enhancement Act.

Todd Akin voted against the Stem Cell Research Enhancement Act.

 

Sponsored and Cosponsored Legislation

Session-110; Bill Number-H R 322; Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007 - Cosponsor

To derive human pluripotent stem cell lines using techniques that do not harm human embryos.

User Comments